Ielasi, A
422  results:
Search for persons X
?
 
?
2

Sorafenib as a second-line treatment after failure of atezo..:

Tovoli, F. ; Boe, M. ; Vivaldi, C....
Digestive and Liver Disease.  56 (2024)  - p. S79 , 2024
 
?
4

Aetiology of hepatocellular carcinoma and response to immun..:

Tovoli, F. ; Chen, R. ; Vivaldi, C....
Digestive and Liver Disease.  56 (2024)  - p. S92-S93 , 2024
 
?
 
?
 
?
 
?
10

Procedural and clinical outcomes of type 0 versus type 1 bi..:

Ielasi, A ; Moscarella, E ; Mangieri, A...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
 
?
11

P2801Hard events after orsiro sirolimus-eluting stent (HERO..:

De Marzo, V ; Parisi, A R ; Donahue, M...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
 
?
12

P5531A systematic follow-up strategy after percutaneous cor..:

Ferlini, M ; Rossini, R ; Musumeci, G...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
 
?
14

P2794Real-world reasons and outcomes for 1-month versus lon..:

Gallone, G ; D'Ascenzo, F ; Di Biasi, M D...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
 
?
15

P2820Contemporary indications, dual antiplatelet therapy st..:

Gallone, G ; D'Ascenzo, F ; Di Biasi, M D...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
 
1-15